AmerisourceBergen Corp. Company Profile (NYSE:ABC)

About AmerisourceBergen Corp. (NYSE:ABC)

AmerisourceBergen Corp. logoAmerisourceBergen Corporation is a pharmaceutical sourcing and distribution services company. The Company's segments include Pharmaceutical Distribution and Other. The Company provides services to healthcare providers, and pharmaceutical and biotech manufacturers. As of June 30, 2016, the Pharmaceutical Distribution segment consists of two operating segments, including the operations of AmerisourceBergen Drug Corporation (ABDC) and AmerisourceBergen Specialty Group (ABSG), which distributes specialty drugs to their customers. Servicing healthcare providers in the pharmaceutical supply channel, the Pharmaceutical Distribution segment's operations provide drug distribution and related services. The Other segment consists of the operations of various segments, including the AmerisourceBergen Consulting Services (ABCS), the World Courier Group, Inc. and the MWI Veterinary Supply, Inc. ABSG operates distribution facilities that focus primarily on complex disease treatment regimens.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drugs Wholesale
  • Sub-Industry: Health Care Distributors
  • Symbol: NYSE:ABC
  • CUSIP: 03073E10
  • Web:
  • Market Cap: $19.87 billion
  • Outstanding Shares: 218,356,000
Average Prices:
  • 50 Day Moving Avg: $86.06
  • 200 Day Moving Avg: $84.81
  • 52 Week Range: $68.38 - $94.50
  • Trailing P/E Ratio: 17.66
  • Foreward P/E Ratio: 14.35
  • P/E Growth: 1.76
Sales & Book Value:
  • Annual Revenue: $149.76 billion
  • Price / Sales: 0.13
  • Book Value: $11.59 per share
  • Price / Book: 7.85
  • Annual Dividend: $1.46
  • Dividend Yield: 1.6%
  • EBIDTA: $2.34 billion
  • Net Margins: 0.91%
  • Return on Equity: 62.44%
  • Return on Assets: 3.93%
  • Debt-to-Equity Ratio: 1.83%
  • Current Ratio: 0.90%
  • Quick Ratio: 0.46%
  • Average Volume: 1.67 million shs.
  • Beta: 0.82
  • Short Ratio: 10.38

Frequently Asked Questions for AmerisourceBergen Corp. (NYSE:ABC)

What is AmerisourceBergen Corp.'s stock symbol?

AmerisourceBergen Corp. trades on the New York Stock Exchange (NYSE) under the ticker symbol "ABC."

How often does AmerisourceBergen Corp. pay dividends? What is the dividend yield for AmerisourceBergen Corp.?

AmerisourceBergen Corp. declared a quarterly dividend on Tuesday, May 9th. Stockholders of record on Monday, May 22nd will be given a dividend of $0.365 per share on Monday, June 5th. This represents a $1.46 dividend on an annualized basis and a dividend yield of 1.60%. The ex-dividend date of this dividend is Thursday, May 18th. View AmerisourceBergen Corp.'s Dividend History.

How were AmerisourceBergen Corp.'s earnings last quarter?

AmerisourceBergen Corp. (NYSE:ABC) announced its quarterly earnings results on Thursday, May, 4th. The company reported $1.77 EPS for the quarter, beating the Zacks' consensus estimate of $1.68 by $0.09. The business had revenue of $37.15 billion for the quarter, compared to the consensus estimate of $38.07 billion. AmerisourceBergen Corp. had a net margin of 0.91% and a return on equity of 62.44%. AmerisourceBergen Corp.'s quarterly revenue was up 4.1% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.68 EPS. View AmerisourceBergen Corp.'s Earnings History.

When will AmerisourceBergen Corp. make its next earnings announcement?

AmerisourceBergen Corp. is scheduled to release their next quarterly earnings announcement on Monday, July, 31st 2017. View Earnings Estimates for AmerisourceBergen Corp..

What guidance has AmerisourceBergen Corp. issued on next quarter's earnings?

AmerisourceBergen Corp. issued an update on its FY17 earnings guidance on Thursday, May, 4th. The company provided EPS guidance of $5.77-5.92 for the period, compared to the Thomson Reuters consensus estimate of $5.82. The company issued revenue guidance of ~$154.9-156.4 billion (+5.5-6.5% y/y), compared to the consensus revenue estimate of $156.38 billion.

Where is AmerisourceBergen Corp.'s stock going? Where will AmerisourceBergen Corp.'s stock price be in 2017?

15 equities research analysts have issued 12 month price objectives for AmerisourceBergen Corp.'s stock. Their predictions range from $83.00 to $105.00. On average, they anticipate AmerisourceBergen Corp.'s stock price to reach $93.63 in the next twelve months. View Analyst Ratings for AmerisourceBergen Corp..

What are analysts saying about AmerisourceBergen Corp. stock?

Here are some recent quotes from research analysts about AmerisourceBergen Corp. stock:

  • 1. According to Zacks Investment Research, "AmerisourceBergen posted mixed first quarter 2017 results with earnings beating the Zacks Consensus Estimate and sales missing the same. However the company’s outcome on a year-over-year basis made a mark. The mixed performance, however, did not have much affected its share price banking on a stable 2017 issued guidance. Notably, in the last three months, AmerisourceBergen has outpaced the Zacks categorized Medical/Dental-Supplies industry. The company has been actively pursuing acquisitions to strengthen its core areas and diversify businesses. The MWI Veterinary acquisition has diversified the company’s existing pharmaceutical distribution & services businesses into the attractive animal health market, which holds huge potential at the moment. The acquisition of PharMEDium added to AmerisourceBergen’s ability to provide market-leading services and solutions to its health system customers. " (2/21/2017)
  • 2. Leerink Swann analysts commented, "We note that even with the impact of the fire, comp trends improved across divisions; absent the fire, core Gap, while still at a disappointing -5% comp, would have seen an 8 and 9 point improvement on a 2 and 3 stack vs. August, respectively." (10/7/2016)

Who are some of AmerisourceBergen Corp.'s key competitors?

Who owns AmerisourceBergen Corp. stock?

AmerisourceBergen Corp.'s stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (0.00%), BlackRock Inc. (0.00%), State Street Corp (3.47%), Fiduciary Management Inc. WI (0.00%), JPMorgan Chase & Co. (0.00%) and Bank of New York Mellon Corp (1.41%). Company insiders that own AmerisourceBergen Corp. stock include Dale Danilewitz, Dermot Mark Durcan, Gina Clark, Henry Wadsworth Mcgee III, James F Cleary Jr, John G Chou, Kathy H Gaddes, Lazarus Krikorian, Lon R Greenberg, Richard C Gozon and Steven H Collis. View Institutional Ownership Trends for AmerisourceBergen Corp..

Who sold AmerisourceBergen Corp. stock? Who is selling AmerisourceBergen Corp. stock?

AmerisourceBergen Corp.'s stock was sold by a variety of institutional investors in the last quarter, including Schroder Investment Management Group, Parametric Portfolio Associates LLC, Acadian Asset Management LLC, Janus Capital Management LLC, FMR LLC, Credit Agricole S A, Burgundy Asset Management Ltd. and State of Wisconsin Investment Board. Company insiders that have sold AmerisourceBergen Corp. stock in the last year include Gina Clark, Henry Wadsworth Mcgee III, John G Chou, Kathy H Gaddes, Lazarus Krikorian and Steven H Collis. View Insider Buying and Selling for AmerisourceBergen Corp..

Who bought AmerisourceBergen Corp. stock? Who is buying AmerisourceBergen Corp. stock?

AmerisourceBergen Corp.'s stock was acquired by a variety of institutional investors in the last quarter, including BlackRock Inc., FIL Ltd, Beutel Goodman & Co Ltd., Bank of America Corp DE, Morgan Stanley, Wells Fargo & Company MN, Fiduciary Management Inc. WI and Vanguard Group Inc.. Company insiders that have bought AmerisourceBergen Corp. stock in the last two years include Dermot Mark Durcan, James F Cleary Jr and Lon R Greenberg. View Insider Buying and Selling for AmerisourceBergen Corp..

How do I buy AmerisourceBergen Corp. stock?

Shares of AmerisourceBergen Corp. can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of AmerisourceBergen Corp. stock cost?

One share of AmerisourceBergen Corp. stock can currently be purchased for approximately $91.00.

Analyst Ratings

Consensus Ratings for AmerisourceBergen Corp. (NYSE:ABC) (?)
Ratings Breakdown: 7 Hold Ratings, 8 Buy Ratings
Consensus Rating:Buy (Score: 2.53)
Consensus Price Target: $93.63 (2.88% upside)

Analysts' Ratings History for AmerisourceBergen Corp. (NYSE:ABC)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
5/17/2017Jefferies Group LLCInitiated CoverageHold -> Hold$95.00HighView Rating Details
4/4/2017Needham & Company LLCInitiated CoverageBuy -> Buy$99.00LowView Rating Details
2/5/2017Credit Suisse Group AGReiterated RatingBuyN/AView Rating Details
1/31/2017Morgan StanleyUpgradeEqual Weight -> OverweightN/AView Rating Details
1/17/2017Leerink SwannUpgradeMarket Perform -> Outperform$95.00N/AView Rating Details
1/12/2017Bank of America CorpUpgradeNeutral -> Buy$94.00N/AView Rating Details
1/3/2017MizuhoDowngradeBuy -> Neutral$83.00N/AView Rating Details
10/10/2016Cleveland ResearchDowngradeBuy -> NeutralN/AView Rating Details
10/4/2016Avondale PartnersUpgradeMarket Perform -> OutperformN/AView Rating Details
8/3/2016Deutsche Bank AGBoost Price TargetHold$83.00 -> $96.00N/AView Rating Details
8/3/2016Citigroup IncBoost Price TargetBuy$100.00 -> $105.00N/AView Rating Details
8/3/2016Barclays PLCBoost Price TargetEqual Weight$83.00 -> $89.00N/AView Rating Details
8/3/2016FBR & CoBoost Price TargetMkt Perform$84.00 -> $90.00N/AView Rating Details
8/2/2016Evercore ISIReiterated RatingHold$93.50N/AView Rating Details
6/4/2016ArgusReiterated RatingBuyN/AView Rating Details
6/1/2016Raymond James Financial, Inc.DowngradeOutperform -> Market PerformN/AView Rating Details
5/6/2016Robert W. BairdReiterated RatingHoldN/AView Rating Details
5/6/2016Royal Bank of CanadaBoost Price TargetOutperform$85.00 -> $100.00N/AView Rating Details
3/15/2016Cowen and CompanyBoost Price Target$95.00 -> $98.00N/AView Rating Details
7/16/2015KeyCorpBoost Price TargetOverweight$61.00 -> $63.00N/AView Rating Details
(Data available from 5/27/2015 forward)


Earnings History for AmerisourceBergen Corp. (NYSE:ABC)
Earnings by Quarter for AmerisourceBergen Corp. (NYSE:ABC)
Earnings History by Quarter for AmerisourceBergen Corp. (NYSE:ABC)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/4/2017Q2 2017$1.68$1.77$38.07 billion$37.15 billionViewListenView Earnings Details
1/31/2017Q117$1.23$1.36$39.00 billion$1.89 billionViewListenView Earnings Details
11/2/2016Q416$1.23$1.30$37.97 billion$37.60 billionViewListenView Earnings Details
8/2/2016Q316$1.27$1.37$36.57 billion$36.90 billionViewListenView Earnings Details
5/5/2016Q216$1.59$1.68$35.84 billion$35.70 billionViewListenView Earnings Details
2/4/2016Q116$1.25$1.27$36.84 billion$36.70 billionViewN/AView Earnings Details
10/29/2015Q415$1.18$1.17$34.62 billion$35.50 billionViewListenView Earnings Details
7/23/2015Q315$1.15$1.20$33.97 billion$34.20 billionViewListenView Earnings Details
4/30/2015Q215$1.19$1.45$32.25 million$32.70 billionViewListenView Earnings Details
1/28/2015Q115$0.96$1.14$31.44 billion$33.60 billionViewListenView Earnings Details
10/30/2014Q414$1.05$1.10$30.78 million$31.60 millionViewListenView Earnings Details
7/24/2014Q314$0.92$1.01$29.23 billion$30.30 billionViewListenView Earnings Details
4/24/2014Q214$1.00$1.06$28.42 million$28.50 millionViewListenView Earnings Details
1/23/2014Q114$0.78$0.80$27.43 billion$29.20 billionViewListenView Earnings Details
10/31/2013Q413$0.74$0.79$23.80 billion$24.50 billionViewListenView Earnings Details
7/24/2013Q3 2013$0.75$0.73$21.36 billion$21.90 billionViewListenView Earnings Details
4/25/2013Q2 2013$0.88$0.87$21.33 billion$20.50 billionViewListenView Earnings Details
1/24/2013Q1 2013$0.67$0.69$21.69 billion$21.50 billionViewListenView Earnings Details
11/1/2012Q412$0.68$0.66$20.35 billion$19.50 billionViewN/AView Earnings Details
7/26/2012$0.69$0.71ViewN/AView Earnings Details
4/26/2012$0.81$0.81ViewN/AView Earnings Details
1/26/2012$0.63$0.62ViewN/AView Earnings Details
11/1/2011$0.61$0.54ViewN/AView Earnings Details
7/28/2011$0.59$0.66ViewN/AView Earnings Details
4/28/2011$0.69$0.78ViewN/AView Earnings Details
2/4/2011$0.54$0.57ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for AmerisourceBergen Corp. (NYSE:ABC)
2017 EPS Consensus Estimate: $5.79
2018 EPS Consensus Estimate: $6.38
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20171$1.22$1.22$1.22
Q2 20171$1.81$1.81$1.81
Q3 20172$1.37$1.40$1.39
Q4 20172$1.36$1.38$1.37
Q1 20182$1.44$1.44$1.44
Q2 20182$1.85$1.91$1.88
Q3 20182$1.51$1.56$1.54
Q4 20182$1.50$1.54$1.52
(Data provided by Zacks Investment Research)


Current Dividend Information for AmerisourceBergen Corp. (NYSE:ABC)
Next Dividend:6/5/2017
Annual Dividend:$1.46
Dividend Yield:1.60%
Dividend Growth:17.00% (3 Year Average)
Payout Ratio:24.37% (Trailing 12 Months of Earnings)
24.87% (Based on This Year's Estimates)
23.03% (Based on Next Year's Estimates)
Track Record:12 Years of Consecutive Dividend Growth
Dividend Payments by Quarter for AmerisourceBergen Corp. (NYSE:ABC)

Dividend History by Quarter for AmerisourceBergen Corp. (NYSE:ABC)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for AmerisourceBergen Corp. (NYSE:ABC)
Insider Ownership Percentage: 27.40%
Institutional Ownership Percentage: 69.11%
Insider Trades by Quarter for AmerisourceBergen Corp. (NYSE:ABC)
Institutional Ownership by Quarter for AmerisourceBergen Corp. (NYSE:ABC)
Insider Trades by Quarter for AmerisourceBergen Corp. (NYSE:ABC)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/1/2017Steven H CollisChairmanSell15,000$81.98$1,229,700.00View SEC Filing  
4/3/2017Steven H CollisChairmanSell15,000$88.35$1,325,250.00View SEC Filing  
3/13/2017Gina ClarkInsiderSell12,000$89.03$1,068,360.00View SEC Filing  
3/3/2017Lazarus KrikorianInsiderSell9,958$91.83$914,443.14View SEC Filing  
2/1/2017Steven H CollisChairmanSell15,000$87.15$1,307,250.00View SEC Filing  
12/1/2016Steven H CollisChairmanSell15,000$77.94$1,169,100.00View SEC Filing  
11/1/2016Steven H CollisChairmanSell15,000$69.85$1,047,750.00View SEC Filing  
10/17/2016Steven H CollisChairmanSell15,000$79.59$1,193,850.00View SEC Filing  
9/21/2016Henry Wadsworth Mcgee IIIDirectorSell3,351$82.10$275,117.10View SEC Filing  
9/7/2016Kathy H GaddesInsiderSell681$88.15$60,030.15View SEC Filing  
8/31/2016John G ChouInsiderSell63,750$85.70$5,463,375.00View SEC Filing  
8/9/2016Lon R GreenbergDirectorBuy4,000$88.59$354,360.00View SEC Filing  
8/5/2016Gina ClarkInsiderSell2,247$89.50$201,106.50View SEC Filing  
3/1/2016Dale DanilewitzEVPSell1,586$86.80$137,664.80View SEC Filing  
12/21/2015Steven H. CollisCEOSell27,148$102.23$2,775,340.04View SEC Filing  
12/7/2015Steven H. CollisCEOSell9,170$100.06$917,550.20View SEC Filing  
12/4/2015Steven H. CollisCEOSell17,978$100.17$1,800,856.26View SEC Filing  
12/2/2015Dermot Mark DurcanDirectorBuy1,000$99.70$99,700.00View SEC Filing  
11/24/2015Richard C. GozonDirectorSell8,780$98.00$860,440.00View SEC Filing  
11/23/2015Richard C. GozonDirectorSell10,666$99.00$1,055,934.00View SEC Filing  
11/18/2015Steven H. CollisCEOSell25,948$100.16$2,598,951.68View SEC Filing  
11/16/2015Dale DanilewitzEVPSell6,388$96.86$618,741.68View SEC Filing  
10/27/2015Steven H. CollisCEOSell1,200$100.97$121,164.00View SEC Filing  
9/21/2015Steven H. CollisCEOSell27,148$105.72$2,870,086.56View SEC Filing  
9/15/2015Henry Wadsworth Mcgee IIIDirectorSell27,592$105.00$2,897,160.00View SEC Filing  
8/20/2015Steven H. CollisCEOSell27,148$104.27$2,830,721.96View SEC Filing  
8/11/2015James F Cleary JrEVPBuy1,000$104.88$104,880.00View SEC Filing  
7/20/2015Steven H CollisCEOSell27,148$114.42$3,106,274.16View SEC Filing  
6/23/2015Gina ClarkEVPSell3,275$112.36$367,979.00View SEC Filing  
6/22/2015Dale DanilewitzEVPSell1,712$112.58$192,736.96View SEC Filing  
6/22/2015Steven H CollisCEOSell27,148$112.37$3,050,620.76View SEC Filing  
5/22/2015Dale DanilewitzEVPSell1,000$114.03$114,030.00View SEC Filing  
5/13/2015June BarryEVPSell2,038$114.36$233,065.68View SEC Filing  
5/11/2015Tim G GuttmanCFOSell16,022$115.25$1,846,535.50View SEC Filing  
5/8/2015John G ChouEVPSell78,656$115.24$9,064,317.44View SEC Filing  
5/8/2015Lazarus KrikorianSVPSell21,802$115.35$2,514,860.70View SEC Filing  
5/5/2015Gina ClarkEVPSell1,400$115.40$161,560.00View SEC Filing  
5/4/2015David W NeuEVPSell62,971$115.43$7,268,742.53View SEC Filing  
3/20/2015James FraryEVPSell73,125$113.78$8,320,162.50View SEC Filing  
3/13/2015Peyton R HowellEVPSell45,984$105.86$4,867,866.24View SEC Filing  
3/9/2015James F Cleary JrEVPBuy1,000$102.54$102,540.00View SEC Filing  
2/27/2015Robert P MauchEVPSell19,415$102.79$1,995,667.85View SEC Filing  
2/19/2015Michael J LongDirectorSell15,170$100.61$1,526,253.70View SEC Filing  
2/13/2015David W NeuEVPSell26,540$99.45$2,639,403.00View SEC Filing  
2/10/2015Lazarus KrikorianSVPSell18,000$96.03$1,728,540.00View SEC Filing  
2/6/2015John G ChouEVPSell21,460$97.70$2,096,642.00View SEC Filing  
2/4/2015Steven H CollisCEOSell145,622$96.01$13,981,168.22View SEC Filing  
1/30/2015Lon R GreenbergDirectorBuy3,000$95.08$285,240.00View SEC Filing  
11/4/2014Henry Wadsworth Mcgee IIIDirectorSell25,109$87.64$2,200,552.76View SEC Filing  
9/15/2014Richard C GozonDirectorSell18,520$776.63$14,383,187.60View SEC Filing  
9/8/2014Edward E HagenlockerDirectorSell4,852$78.09$378,892.68View SEC Filing  
6/20/2014Peyton R HowellSVPSell45,000$71.53$3,218,850.00View SEC Filing  
6/11/2014Steven H CollisCEOSell157,500$71.83$11,313,225.00View SEC Filing  
5/22/2014John ChouEVPSell37,500$71.28$2,673,000.00View SEC Filing  
2/18/2014Edward HagenlockerDirectorSell13,836$68.52$948,042.72View SEC Filing  
2/7/2014Richard GozonDirectorSell19,784$66.10$1,307,722.40View SEC Filing  
1/6/2014Henry Wadsworth Mcgee IIIDirectorSell9,449$69.62$657,839.38View SEC Filing  
11/5/2013Steven H CollisCEOSell150,000$67.20$10,080,000.00View SEC Filing  
9/10/2013James FrarySVPSell15,000$59.03$885,450.00View SEC Filing  
8/30/2013John ChouEVPSell33,518$56.90$1,907,174.20View SEC Filing  
6/17/2013Jane E Md HenneyDirectorSell36,149$55.16$1,993,978.84View SEC Filing  
6/6/2013David W NeuSVPSell42,187$52.95$2,233,801.65View SEC Filing  
5/30/2013Jane E Md HenneyDirectorSell1,008$54.53$54,966.24View SEC Filing  
5/2/2013Steven H CollisCEOSell245,258$54.41$13,344,487.78View SEC Filing  
8/9/2012David W NeuSVPSell9,284$38.84$360,590.56View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for AmerisourceBergen Corp. (NYSE:ABC)
Latest Headlines for AmerisourceBergen Corp. (NYSE:ABC)
DateHeadline logo$1.37 Earnings Per Share Expected for AmerisourceBergen Corp. (ABC) This Quarter - May 25 at 4:24 PM logoNew Stocks On Exec Comp And ROIC Model Portfolio: May 2017 - May 23 at 3:17 PM logoAmerisourceBergen Corp. : ABC-US: Dividend Analysis : May 22nd, 2017 (record date) : By the numbers : May 23, 2017 - May 23 at 3:17 PM logoETFs with exposure to AmerisourceBergen Corp. : May 22, 2017 - May 22 at 3:15 PM logoServices Stocks Under Scanner -- Rite Aid, Cardinal Health, AmerisourceBergen, and McKesson - May 19 at 9:51 AM logoAmerisourceBergen Corp. :ABC-US: Earnings Analysis: Q2, 2017 By the Numbers : May 19, 2017 - May 19 at 9:50 AM logoAmerisourceBergen Corp. (ABC) Now Covered by Analysts at Jefferies Group LLC - May 18 at 6:32 PM logoJefferies Group Comments on AmerisourceBergen Corp.'s Q3 2017 Earnings (ABC) - May 18 at 9:26 AM logoAmerisourceBergen Corp. (ABC) Upgraded at Vetr Inc. - May 18 at 12:56 AM logoJefferies: Weakening Generic Drug Prices Putting Pressure On 3 Healthcare Stocks - May 17 at 8:19 PM logoJefferies: Weakening Generic Drug Prices Putting Pressure On 3 Healthcare Stocks - Benzinga - May 17 at 3:16 PM logoJefferies: Weakening Generic Drug Prices Putting Pressure On 3 Healthcare Stocks - Benzinga - May 17 at 3:16 PM logoAmerisourceBergen Corporation (Holding Co) (ABC) Ex-Dividend Date Scheduled for May 18, 2017 - Nasdaq - May 17 at 12:44 PM logoAmerisourceBergen Corp. (ABC) Given Average Recommendation of "Buy" by Brokerages - May 15 at 3:15 PM logoAmerisourceBergen Corp. – Value Analysis (NYSE:ABC) : May 11, 2017 - May 11 at 8:24 PM logoAmerisourceBergen Corp. breached its 50 day moving average in a Bullish Manner : ABC-US : May 10, 2017 - May 10 at 9:36 AM logoAmerisourceBergen Corp. (ABC) Cut to "Buy" at Vetr Inc. - May 10 at 12:16 AM logoAmerisourceBergen Corp. to Issue Quarterly Dividend of $0.37 (ABC) - May 9 at 10:56 AM logoQ3 2017 EPS Estimates for AmerisourceBergen Corp. (ABC) Lowered by Leerink Swann - May 8 at 9:10 AM logoAmerisourceBergen (ABC) Beats on Q2 Earnings, Lags Revenues - Yahoo Finance - May 5 at 3:15 PM logoAmerisourceBergen (ABC) Beats on Q2 Earnings, Lags Revenues - May 5 at 1:19 AM logoEdited Transcript of ABC earnings conference call or presentation 4-May-17 12:30pm GMT - May 5 at 1:19 AM logoAmerisourceBergen (ABC) Q2 2017 Results - Earnings Call Transcript - May 4 at 8:17 PM logoAmerisourceBergen Reports Second Quarter Fiscal Year 2017 Results - May 4 at 8:17 PM logoAmerisourceBergen (ABC) Q2 Earnings Beat, Sales Miss - May 4 at 8:17 PM logoAmerisourceBergen Corp. (ABC) Releases Earnings Results, Beats Expectations By $0.09 EPS - May 4 at 3:36 PM logoCost controls help drug wholesaler AmerisourceBergen's profit beat - Reuters - May 4 at 3:15 PM logoAmerisourceBergen Corp. (ABC) Updates FY17 Earnings Guidance - May 4 at 11:17 AM logoMarkets Right Now: Stocks edge higher in early trading - May 4 at 9:48 AM logoAmerisourceBergen tops 2Q profit forecasts - May 4 at 6:48 AM logoAmerisourceBergen and Express Scripts sign pharmaceutical supply agreement - May 3 at 6:03 AM logoAmerisourceBergen (ABC) Q2 Earnings: Will it Disappoint? - May 3 at 6:03 AM logoAmerisourceBergen Corp. (ABC) Chairman Steven H. Collis Sells 15,000 Shares - May 2 at 9:24 PM logoZacks: Analysts Expect AmerisourceBergen Corp. (ABC) Will Post Earnings of $1.71 Per Share - May 2 at 11:24 AM logoAmerisourceBergen Corp. (ABC) Set to Announce Earnings on Thursday - May 2 at 8:26 AM logoSomewhat Positive News Coverage Likely to Impact AmerisourceBergen Corp. (ABC) Share Price - May 2 at 7:46 AM logoCorrection Is Over for AmerisourceBergen - May 2 at 5:28 AM logoSomewhat Favorable Media Coverage Somewhat Likely to Impact AmerisourceBergen Corp. (ABC) Share Price - April 29 at 8:40 AM logoAmerisourceBergen CEO on drug pricing: 'We’ve had some bad actors' - April 26 at 3:24 PM logoAmerisourceBergen Corp. (ABC) Earns News Impact Rating of 0.12 - April 26 at 9:14 AM logoAmerisourceBergen: Total Return With Growing Dividend - Seeking Alpha - April 25 at 6:25 AM logoSomewhat Positive Press Coverage Extremely Likely to Impact AmerisourceBergen Corp. (ABC) Stock Price - April 23 at 7:32 AM logoPharmacy group starts division HQ campus in Carrollton with plans to employ 3000 - Dallas Business Journal - April 20 at 3:15 PM logoSomewhat Positive Media Coverage Likely to Affect AmerisourceBergen Corp. (ABC) Share Price - April 20 at 7:29 AM logoAmerisourceBergen (ABC) Up 4.1% Since Earnings Report: Can It Continue? - Nasdaq - April 19 at 3:15 PM logoAmerisourceBergen (ABC) Up 4.1% Since Earnings Report: Can It Continue? - April 19 at 3:15 PM logoETFs with exposure to AmerisourceBergen Corp. : April 19, 2017 - April 19 at 3:15 PM logo[$$] Cardinal Health’s $6.1 Billion Deal for Some Medtronic Operations Raises Debt Concerns - April 19 at 5:19 AM logoAmerisourceBergen Corp. (ABC) Rating Increased to Strong-Buy at Vetr Inc. - April 19 at 12:29 AM logoAmerisourceBergen Enters Oversold Territory - Nasdaq - April 18 at 3:15 PM



AmerisourceBergen Corp. (ABC) Chart for Saturday, May, 27, 2017

This page was last updated on 5/27/2017 by Staff